The FDA Just Made Its Most Controversial Drug Approval of the Year — Fortune

Patient advocacy groups and Sarepta Therapeutics srpt won a stunning victory on Monday with a conditional approval of the biotech’s drug for a rare disease. The Food and Drug Administration’s (FDA) thumbs-up, however, comes amid the intense intra-agency controversy over the therapy. Not to mention a concerted lobbying campaign on its behalf, leading critics to…

via The FDA Just Made Its Most Controversial Drug Approval of the Year — Fortune

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s